Shingles vaccine may lower risk of stroke and heart failure

Being vaccinated against shingles has been linked to a lower risk of cardiovascular disease before, but now a study suggests that the vaccine that is currently being used reduces the odds more than earlier versions of the shot

The top 3

  1. Highest Efficacy Against Shingles: The Shingrix vaccine is highly effective at preventing shingles, with 97% efficacy in adults aged 50-69 and 91% in those 70 and older. This protection can last for more than a decade.
  2. Reduces Postherpetic Neuralgia Risk: The shingles vaccine is the best way to prevent postherpetic neuralgia (PHN), a severe and long-lasting nerve pain complication of shingles. Shingrix has shown 91% efficacy in preventing PHN in adults 50 and older, and 89% in those 70 and older.
  3. Lowers Cardiovascular Event Risk: Shingles vaccination may significantly reduce the risk of major adverse cardiac events, including heart attack (32% lower risk), stroke (25% lower risk), and heart failure (25% lower risk) in older adults with heart disease. It has also been associated with an 18% reduction in cardiovascular events in adults 18 and older, and 16% in adults 50 and older.

Sources

Open the full topic